A Dark Vector Cognition product

Item 6. Exhibits

7K characters. Original on sec.gov ·

Item 6. Exhibits

The exhibits listed in this Item 6 are filed as part of this Quarterly Report on Form 10-Q. Exhibits marked with an asterisk (*) are management contracts or compensatory plans or arrangements. Exhibits other than those listed are omitted because they are not required to be listed or are not applicable. Pursuant to Item 601(b)(4)(iii) of Regulation S-K, the Registrant hereby agrees to furnish to the U.S. Securities and Exchange Commission a copy of any omitted instrument that is not required to be listed.

INDEX TO EXHIBITS

10Material contracts
10.1*Restrictive Covenant Agreement dated November 15, 2024 between the Registrant and Steven H. Nelson.
10.2*Change in Control Agreement effective as of November 15, 2024 between the Registrant and Steven H. Nelson.
10.3*Restrictive Covenant Agreement dated March 29, 2025 between the Registrant and Brian Newman.
10.4*Change in Control Agreement effective as of April 1, 2025 between the Registrant and Brian Newman.
10.5*†The Registrant’s Severance Plan for Non-Store Employees, Amended and Restated as of March 15, 2026.
10.6*Form of Restricted Stock Unit Agreement between the Registrant and selected employees of the Registrant.
10.7*Form of Nonqualified Stock Option Agreement between the Registrant and selected executives of the Registrant.
10.8*Form of Nonqualified Stock Option Agreement between the Registrant and selected employees of the Registrant.
10.9*†Form of Performance Stock Unit Agreement between the Registrant and selected employees of the Registrant.
15Letter re: unaudited interim financial information
15.1Letter from Ernst & Young LLP acknowledging awareness of the use of a report dated May 6, 2026 related to their reviews of interim financial information.
31Rule 13a-14(a)/15d-14(a) Certifications
31.1Certification by the Chief Executive Officer.
31.2Certification by the Chief Financial Officer.
32Section 1350 Certifications
32.1Certification by the Chief Executive Officer.
32.2Certification by the Chief Financial Officer.
101
101The following materials from the CVS Health Corporation Quarterly Report on Form 10-Q for the three months ended March 31, 2026 formatted in Inline XBRL: (i) the Condensed Consolidated Statements of Operations, (ii) the Condensed Consolidated Statements of Comprehensive Income, (iii) the Condensed Consolidated Balance Sheets, (iv) the Condensed Consolidated Statements of Cash Flows, (v) the Condensed Consolidated Statements of Shareholders’ Equity and (vi) the related Notes to Condensed Consolidated Financial Statements. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
104
104Cover Page Interactive Data File - The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, formatted in Inline XBRL (included as Exhibit 101).

† The appendixes to this exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Registrant agrees to furnish supplementally a copy of all omitted appendixes to the Securities and Exchange Commission upon its request.

Form 10-Q Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

CVS HEALTH CORPORATION
Date:May 6, 2026By:/s/ Brian O. Newman
Brian O. Newman
Executive Vice President and Chief Financial Officer

Previous: Item 5. Other Information